New treatment with omalizumab may desensitize kids with milk allergies
New treatment may desensitize kids with milk allergies, say researchers at Stanford and Boston – Milk allergy is the most common, affecting 2.5 percent of children under age 3. In a small clinical study, researchers report effectively desensitizing milk-allergic patients by increasing their exposure to milk in tandem with an allergy drug called omalizumab, allowing children to build up resistance quickly with limited allergic reactions.